Moneycontrol
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals

Celestial Biolabs

BSE: 532871|NSE: CELESTIAL|ISIN: INE221I01017|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Dec 18, 16:00
18.90
-0.05 (-0.26%)
VOLUME 21,711
LIVE
NSE
Dec 18, 15:51
18.95
0.1 (0.53%)
VOLUME 50,686
Announcements on Celestial Bio

14th-Dec-2017 17:30Source: BSE

Celestial Biolabs- Financial Results For The Quarter / Half Year Ended On 30Th September, 2017

Financial results for the quarter / half year ended on 30th September, 2017 alongwith Limited Review Report are enclosed

6th-Dec-2017 17:09Source: BSE

Celestial Biolabs- Prior Intimation Of The Board Meeting And Audit Committee Meeting To Be Held On 14.12.2017 - Un-Audited Financial Results

Pursuant to Regulation 29 (1) (a) of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 this is to intimate you that a meeting of the Board of Directors and Audit Committee of the ...

3rd-Nov-2017 17:42Source: BSE

Celestial Biolabs- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dr A N Singh

30th-Oct-2017 17:33Source: BSE

Celestial Biolabs- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dr. A N Singh

27th-Oct-2017 16:48Source: BSE

Celestial Biolabs- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dr A N Singh

27th-Oct-2017 11:58Source: BSE

Celestial Biolabs- Compliance Certificate For The Period Ended September 30, 2017

Please find enclosed the certificate under Regulation 7(3) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the half year ended Septemb...

27th-Oct-2017 11:56Source: BSE

Celestial Biolabs- CERTIFICATE UNDER REGULATION 40 (9) OF SEBI (LISTING OBLIGATIONS & DISCLOSURE REQUIREMENTS) REGULATIONS, 2015

Pursuant to Regulation 40(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing the certificate received from the practicing company secretary for the ha...

20th-Oct-2017 16:40Source: BSE

Celestial Biolabs- Statement Of Investor Complaints For The Quarter Ended 30Th September, 2017

Statement of Investor Complaints for the quarter ended 30th September, 2017 as required under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

20th-Oct-2017 10:28Source: BSE

Celestial Biolabs- Shareholding for the Period Ended September 30, 2017

Celestial Biolabs Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2017. For more details, kindly

10th-Oct-2017 13:26Source: BSE

Celestial Bio- Revised Financial Results For The Quarter Ended 30Th June, 2017

Revised Financial results alongwith limited review report for the quarter ended 30th June, 2017 are enclosed

1 2 3 4 5 Next >>
Quick Links for Celestial Biolabs
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.